Related Experiment Video
Updated: Mar 2, 2026

09:41
Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
Published on: February 25, 2021
25.6K
Engineering liposomal nanoparticles for targeted gene therapy
C Zylberberg1, K Gaskill1, S Pasley1
1Akron Biotech, Boca Raton, FL, USA.
Gene Therapy
|May 16, 2017
Summary
Targeted liposomes enhance genetic material delivery by overcoming cellular barriers. Advances in ligand and cationic lipid design are crucial for effective liposome nanoparticle-based gene therapy.
Area of Science:
- Biotechnology and Nanomedicine
- Molecular and Cellular Biology
Background:
- Liposome-mediated delivery of genetic material faces significant challenges, including cellular entry, endosomal escape, and nuclear uptake.
- Understanding lipid nanoparticle-cell interactions is crucial for improving gene delivery efficacy.
Purpose of the Study:
- To review recent breakthroughs in targeted liposome-based agents for genetic material delivery.
- To highlight advancements in ligand and cationic lipid design for enhanced gene therapy.
Main Methods:
- Review of recent mechanistic studies and rational design approaches for targeted delivery.
- Analysis of strategies involving modification of lipid nanoparticles with target-specific ligands.
- Examination of physical and chemical specifications of liposome composition.
Main Results:
- Targeted delivery strategies, including ligand modification, show promise in enhancing intracellular uptake.
- Control over liposome composition (e.g., lipid-to-DNA charge, size, ligand complexation) is integral to performance.
- Recent in vivo advances demonstrate the potential of these systems.
Conclusions:
- Targeted liposomes are critical for the future of liposome nanoparticle-based gene therapy.
- Continued development in ligand and cationic lipid design will drive clinical advances.
- Improved understanding of nanoparticle-cell interactions is key to overcoming delivery obstacles.
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
51
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
51
Gene Therapy
27.8K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.8K
Site-Targeted Drug Delivery Systems: Polymeric Carriers
63
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
63

